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A passive hemagglutination inhibition assay was studied by using a hyperimmune serum from rabbits immunized with whole yeast cells (Candida albicans group A). This technique was effective at detecting small amounts of laboratoryprepared mannan or a whole-cell extract of C. albicans. Of 32 patients with documented disseminated candidiasis that were tested, 19 showed evidence of circulating antigen by passive hemagglutination inhibition. Three of these patients showed only partial, rather than complete, inhibition. Among 22 colonized patients, 4 showed partial inhibition, and none of 49 normal controls demonstrated inhibition. All of the sera were tested for antibody by agglutination, immunodiffusion, and passive hemagglutination. This last technique added increased sensitivity, but not specificity, to the standard tests already in use. Fourfold or greater titer rises by passive hemagglutination occurred in fewer than one-third of patients with invasive candidiasis and developed in more than one-half of patients who were colonized and did not require systemic anticandida therapy.
Whether or not a patient has candidiasis requiring treatment is one of the most difficult decisions a clinician faces in infectious diseases (1, 3). Sputum, urine, and even blood may yield the organism on culture without reflecting invasive disease. On the other hand, invasive infection may be unaccompanied by positive cultures. Serological tests for antibody as evidence of invasive candidiasis have been studied widely, but both false-positive and false-negative results can occur, especially in immunosuppressed patients who are at high risk (2). Because of this, attempts have been made to detect circulating antigens, cell constituents, or metabolites as indicators of a candida infection requiring therapy (5-7). A passive hemagglutination inhibition test which has shown promise has been described previously (7) . We studied patients who were documented as colonized or Antiserum. New Zealand rabbits weighing 4 to 5 kg were immunized once a week, alternately intravenously or intramuscularly, with a 1% suspension of whole C. albicans group A for 2 to 3 months. Titers were determined weekly by agglutination and immunodiffusion. Rabbits were exsanguinated when the agglutination titer reached 1:1,024.
Antibody detection. Three methods of antibody detection were compared. Immunodiffusion and agglutination tests were done as previously described (2, 8).
The third method was a passive hemagglutination assay (PHA) with concanavalin A to coat glycoproteins and polysaccharides on sheep erythrocytes (SRBC) (4). SRBC were sensitized with 50 gg of concanavalin A per ml (4). The candida antigen used to coat SRBC was the same as the one used for the immunodiffusion test (8) test wells. Sera to be tested for inhibition (previously heat inactivated and SRBC absorbed) were then serially diluted starting at 1:2 in the hyperimmune rabbit serum. Positive controls were normal human serum which contained candida antigen (diluted 1:32) and another which contained mannan (500 ,g/ml), and negative controls were normal human sera. The normal human sera used were chosen because they had no detectable candida antibody by the PHA test. After a 1-h incubation at room temperature, 25 il of coated SRBC (0.5% suspension) or uncoated control cells was added, and the plates were incubated overnight at 4°C. The inhibition titer was the highest dilution which inhibited agglutination of the antigencoated SRBC with the rabbit antiserum. The positive control inhibited to a titer of 1:16,834, whereas the negative controls showed no inhibition.
RESULTS
The PHA-I test was effective for detecting small amounts of C. albicans group A mannan. As (Table 2) . Among the 13 patients with disseminated candidiasis and negative PHA-I reactions, 9 were tested on several occasions, and 4 of these 9 patients (44%) showed fourfold or greater rises in antibody titer by PHA. Among the 18 colonized patients with negative PHA-I reactions, 12 were tested on multiple days, and 7 (58%) showed a significant rise in antibody titer.
The stability of the reactions was tested by repeating PHA-I tests 6 months after the sera were stored at -20°C. Of 26 reactions, 10 were stable, 2 decreased by 3 dilutions, and 14 became negative. There were no tests done between 2 and 6 months after storing the blood. DISCUSSION The PHA-I test was effective at detecting small amounts of laboratory-prepared mannan or a whole-cell extract of C. albicans. The PHA-I test was also inhibited by sera from patients, with two types of reactions occurring ( 
